Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOCHA Trial: Montelukast Following ACL Reconstruction
NCT04572256Phase 1Recruiting
- Start
- Feb 2021
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in Post-traumatic osteoarthritis (PTOA) comparing Montelukast with Placebo (2 arms). Primary endpoints: Serum prostaglandin E2 at 1 year, T1rho relaxation time on MRI at 1 year and 2 more. Started Feb 2021; status: recruiting.
02
Drugs
montelukast
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT04572256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572256.